Pharma Mar | PHM - Cost Of Sales

Stock Price
76.25
Daily Change
0.10 0.13%
Monthly
-3.05%
Yearly
-15.89%
Q1 Forecast
76.83

Pharma Mar reported EUR2.3M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Almirall EUR 193.79M 12.62M Jun/2025
Avita Medical AUD 3.47M 1.19M Jun/2025
Ionis Pharmaceuticals USD 2.34M 1.81M Sep/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Moderna USD 207M 88M Sep/2025
Organon & Co USD 745M 25M Sep/2025
Pharma Mar EUR 2.3M 477K Sep/2025
Revvity USD 324.34M 3.38M Sep/2025
Viatris USD 2.39B 139.2M Sep/2025
Xeris Pharmaceuticals USD 13.71M 1.81M Sep/2025